<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-94 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-94</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-94</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of proposed causes or mechanisms of Alzheimer's disease, and any methods or biomarkers used for its detection, including evidence, results, and limitations.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>proposed_cause</strong></td>
                        <td>str</td>
                        <td>A proposed cause or mechanism of Alzheimer's disease described in the paper (e.g., amyloid-beta accumulation, tau pathology, genetic mutations, inflammation, vascular factors, etc.).</td>
                    </tr>
                    <tr>
                        <td><strong>cause_evidence</strong></td>
                        <td>str</td>
                        <td>A concise summary of the evidence supporting or refuting the proposed cause, including key findings, study type (e.g., human, animal, in vitro), and any relevant statistics or results.</td>
                    </tr>
                    <tr>
                        <td><strong>detection_method</strong></td>
                        <td>str</td>
                        <td>A method or technique used to detect Alzheimer's disease (e.g., CSF biomarker, blood biomarker, PET imaging, MRI, cognitive test, etc.).</td>
                    </tr>
                    <tr>
                        <td><strong>biomarker_or_finding</strong></td>
                        <td>str</td>
                        <td>The specific biomarker, imaging finding, or clinical feature used for detection (e.g., amyloid-beta42 in CSF, tau PET signal, hippocampal atrophy on MRI, MMSE score, etc.).</td>
                    </tr>
                    <tr>
                        <td><strong>detection_performance</strong></td>
                        <td>str</td>
                        <td>Performance metrics of the detection method, such as sensitivity, specificity, accuracy, AUC, or other relevant statistics. Include numerical values and units if available.</td>
                    </tr>
                    <tr>
                        <td><strong>detection_stage</strong></td>
                        <td>str</td>
                        <td>The stage of Alzheimer's disease at which the detection method is effective (e.g., preclinical, mild cognitive impairment, dementia stage, etc.).</td>
                    </tr>
                    <tr>
                        <td><strong>study_type</strong></td>
                        <td>str</td>
                        <td>The type of study providing the evidence (e.g., human clinical study, animal model, in vitro, meta-analysis, review, etc.).</td>
                    </tr>
                    <tr>
                        <td><strong>limitations_or_counter_evidence</strong></td>
                        <td>str</td>
                        <td>Any limitations, challenges, or counter-evidence mentioned regarding the proposed cause or detection method (e.g., conflicting results, small sample size, lack of specificity, etc.).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="section">
            <h2>Extraction Schema (Debug)</h2>
            <pre><code>{
    "id": "extraction-schema-94",
    "schema": [
        {
            "name": "proposed_cause",
            "type": "str",
            "description": "A proposed cause or mechanism of Alzheimer's disease described in the paper (e.g., amyloid-beta accumulation, tau pathology, genetic mutations, inflammation, vascular factors, etc.)."
        },
        {
            "name": "cause_evidence",
            "type": "str",
            "description": "A concise summary of the evidence supporting or refuting the proposed cause, including key findings, study type (e.g., human, animal, in vitro), and any relevant statistics or results."
        },
        {
            "name": "detection_method",
            "type": "str",
            "description": "A method or technique used to detect Alzheimer's disease (e.g., CSF biomarker, blood biomarker, PET imaging, MRI, cognitive test, etc.)."
        },
        {
            "name": "biomarker_or_finding",
            "type": "str",
            "description": "The specific biomarker, imaging finding, or clinical feature used for detection (e.g., amyloid-beta42 in CSF, tau PET signal, hippocampal atrophy on MRI, MMSE score, etc.)."
        },
        {
            "name": "detection_performance",
            "type": "str",
            "description": "Performance metrics of the detection method, such as sensitivity, specificity, accuracy, AUC, or other relevant statistics. Include numerical values and units if available."
        },
        {
            "name": "detection_stage",
            "type": "str",
            "description": "The stage of Alzheimer's disease at which the detection method is effective (e.g., preclinical, mild cognitive impairment, dementia stage, etc.)."
        },
        {
            "name": "study_type",
            "type": "str",
            "description": "The type of study providing the evidence (e.g., human clinical study, animal model, in vitro, meta-analysis, review, etc.)."
        },
        {
            "name": "limitations_or_counter_evidence",
            "type": "str",
            "description": "Any limitations, challenges, or counter-evidence mentioned regarding the proposed cause or detection method (e.g., conflicting results, small sample size, lack of specificity, etc.)."
        }
    ],
    "extraction_query": "Extract any mentions of proposed causes or mechanisms of Alzheimer's disease, and any methods or biomarkers used for its detection, including evidence, results, and limitations.",
    "supporting_theory_ids": [],
    "model_str": "openai/gpt-4.1-2025-04-14"
}</code></pre>
        </div>
    </div>
</body>
</html>